CNS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 380 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 176-200 of 380 matching filings.

Per page
25
Current page
8
S-3 File 333-275671

REGISTRATION STATEMENT

Filing date
20 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
15 Nov 2023
Reporting date
15 Nov 2023
Next action
Verify source filing
10-Q File 001-39126

QUARTERLY REPORT

Filing date
14 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
18 Oct 2023
Reporting date
18 Oct 2023
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
17 Oct 2023
Reporting date
16 Oct 2023
Next action
Verify source filing
4/A

4/A filing

Filing date
12 Oct 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
12 Oct 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
12 Oct 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
12 Oct 2023
Reporting date
14 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
12 Oct 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
12 Oct 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Sep 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Sep 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Sep 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Sep 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Sep 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Sep 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
19 Sep 2023
Reporting date
14 Sep 2023
Next action
Verify source filing
4

4 filing

Filing date
23 Aug 2023
Reporting date
22 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Aug 2023
Reporting date
16 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
15 Aug 2023
Reporting date
11 Aug 2023
Next action
Verify source filing
DEF 14A File 001-39126

DEFINITIVE PROXY

Filing date
14 Aug 2023
Reporting date
14 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39126

QUARTERLY REPORT

Filing date
14 Aug 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .